Actively Recruiting

Age: 18Years +
All Genders
ID04736667

Mitral Valve Screening Survey (MVSS)

Led by Medstar Health Research Institute · Updated on 2025-08-29

1000

Participants Needed

16

Research Sites

N/A

Total Duration

On this page

AI-Summary

What this Trial Is About

This research aims to better understand patients with mitral valve disease who do not qualify for transcatheter mitral valve intervention (TMVI). It focuses on examining their clinical and anatomical characteristics, as well as tracking their health outcomes over time. The study collects detailed information to learn more about the natural history of those who fail screening for these investigational heart valve procedures. The study is an observational registry involving patients referred for TMVI but found ineligible for these treatments after screening. There are no assigned treatments or interventions since the study observes patients who are not candidates for TMVI. Data collected includes baseline health information, imaging characteristics, and reasons for screening failure. Participants will be followed to record outcomes such as mortality, hospitalizations, and any mitral valve interventions at intervals including 30 days, 1 year, and annually for up to 5 years. Researchers will monitor all-cause mortality at 1 year as the primary outcome and collect data on hospitalizations and interventions as secondary outcomes. The study began in August 2021 and is expected to continue through February 2027.

CONDITIONS

Brief Title

Mitral Valve Screening Survey

Who Can Participate

Age: 18Years +
All Genders

Eligibility Criteria

Eligible

You may qualify if you...

  • Subject failed screening for TMVI
Not Eligible

You will not qualify if you...

  • Under 18 years of age
  • Subject unable or unwilling to give informed consent
  • Subject proceeded with TMVI

AI-Screening

AI-Powered Screening

Complete this quick 3-step screening to check your eligibility

1
2
3
+1

Your Study Journey

Screening

Duration - 2 to 4 weeks

Participants are screened for eligibility to participate in the trial.

1 visit (in-person)

Long-term Monitoring

Duration - Up to 5 years

Participants with symptomatic mitral valve disease who fail screening for transcatheter mitral valve interventions are observed to collect clinical outcomes and relevant data.

Visits at 30 days, 1 year, and annually up to 5 years

Trial Site Locations

Total: 16 locations

1

Phoenix Cardiovascular Research Group

Phoenix, Arizona, United States, 85016

Actively Recruiting

2

Keck Hospital of USC

Los Angeles, California, United States, 90033

Actively Recruiting

3

MedStar Washington Hospital Center

Washington D.C., District of Columbia, United States, 20010

Actively Recruiting

4

Morton Plant Hospital

Clearwater, Florida, United States, 33756

Actively Recruiting

5

HealthPark Medical Center

Fort Myers, Florida, United States, 33908

Actively Recruiting

6

Northwestern University

Chicago, Illinois, United States, 60611

Actively Recruiting

7

MercyOne Iowa Heart Center

West Des Moines, Iowa, United States, 50266

Actively Recruiting

8

University of Kansas Medical Center

Kansas City, Kansas, United States, 66103

Actively Recruiting

9

Massachusetts General Hospital

Boston, Massachusetts, United States, 02114

Actively Recruiting

10

Ascension St. John's Hospital

Detroit, Michigan, United States, 48236

Actively Recruiting

11

NYU Langone Health - Long Island

Mineola, New York, United States, 11501

Actively Recruiting

12

The Ohio State University

Columbus, Ohio, United States, 43210

Actively Recruiting

13

Oregon Health Sciences University

Portland, Oregon, United States, 98239

Actively Recruiting

14

Aurora St. Luke's Medical Center

Milwaukee, Wisconsin, United States, 53215

Actively Recruiting

15

St. Paul's Hospital

Vancouver, British Columbia, Canada

Actively Recruiting

16

Unity Health Toronto; St. Michael's Hospital

Toronto, Ontario, Canada

Actively Recruiting

Loading map...

Research Team

K

Kassandra Lopez

J

Jake Sutton

How is the study designed?

Study Type

OBSERVATIONAL

Masking

N/A

Allocation

N/A

Model

N/A

Primary Purpose

N/A

Number of Arms

1

Similar Trials

Abbott Cephea Mitral Valve Disease Registry to Collect Data ...

Mitral Regurgitation

Actively Recruiting

22 locations

Choice of Optimal Transcatheter Treatment for Mitral Insuffi...

Mitral Regurgitation

Actively Recruiting

43 locations

Cohort Observing Mechanisms, Progression and Sequelae of Val...

Heart Valve Disease

Actively Recruiting

15 locations

Frequently Asked Questions

Have more questions? Get in touch with our team for quick support

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here

Published Research Related To This Trial

The Clinical Profile and Natural History of Patients Who Fail Screening for Transcatheter Mitral Valve Replacement: Rationale and Design of the Prospective Multicenter Mitral Valve Screening Survey (MVSS).

Giorgio A Medranda, Toby Rogers, Thomas Modine...

https://pubmed.ncbi.nlm.nih.gov/36266153